|
Related Articles |
Abuse of methylphenidate in Germany: data from spontaneous reports of adverse drug reactions.
Psychiatry Res. 2014 Jan 30;215(1):252-4
Authors: Gahr M, Freudenmann RW, Hiemke C, Kölle MA, Schönfeldt-Lecuona C
Abstract
To retrieve insights into abuse/dependence of methylphenidate (MPH) in Germany, a query of a pharmacovigilance database was performed (observation interval: 1993 until 2012). From 1190 reports of any ADR related to MPH, n=23 (2%) cases of MPH abuse were identified (mean age 29 years; male sex 78%; mean daily MPH-dosage 111 ± 126.6 mg). As oral application was predominant (70%), the majority of reported cases of MPH abuse might be due to pharmacologic neuroenhancement.
PMID: 24289907 [PubMed – indexed for MEDLINE]

